Abstract
Abdul Basit holds the position of Professor of Pharmaceutics at the UCL School of Pharmacy, University College London (UK). Basit is an internationally leading authority on oral drug delivery, digital health and innovative pharmaceutical technologies including 3D printing. Basit is a world authority on translational research; he has founded two spin-out companies (FabRx Ltd and Intract Pharma, both in London, UK) and has invented several drug products that have entered the clinic. More than a million patients to date have benefited from the treatments originating from his laboratory. Across his career, Basit has received prestigious awards from the American Association of Pharmaceutical Scientists, Academy of Pharmaceutical Sciences, GlaxoSmithKline and AstraZeneca and was listed among the world’s most highly influential researchers in 2019.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
